Fierce Healthcare reports…
Blue Cross and Blue Shield of Minnesota is teaming up with Minnesota Oncology on a five-year value-based agreement for cancer care.
The collaboration will begin Sept. 1, and the payer and provider will share risk for the overall cost of cancer for members treated at Minnesota Oncology, the companies announced. As part of the deal, Minnesota Oncology has agreed to a set of evidence-based principles to guide care, so Blue Cross will waive prior authorization for certain treatments that are often overutilized.
Telehealth plays a role in the process…
Blue Cross members treated at Minnesota Oncology clinics will also receive more coordinated approach to care. Amezcua said that the model will free oncologists to provide additional services such as telehealth, as they’re not being paid based on a claims form checklist.
Minnesota Oncology also offers patients access to nonclinical supports such as nutrition, behavioral health and genetic counseling. It also provides remote monitoring, advanced care planning and palliative care for patients who need those services.
“Cancer patients face a big challenge, and we remain committed to providing comprehensive care including state-of-the-art therapies, precision medicine, genetic testing, palliative care and access to clinical trials,” John Schwerkoskie, M.D., president of Minnesota Oncology, said in a statement.